Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2062324
Max Phase: Preclinical
Molecular Formula: C46H49F5N4O8
Molecular Weight: 730.82
Molecule Type: Small molecule
Associated Items:
ID: ALA2062324
Max Phase: Preclinical
Molecular Formula: C46H49F5N4O8
Molecular Weight: 730.82
Molecule Type: Small molecule
Associated Items:
Synonyms (2): TCMDC-141316 | TCMDC-141316
Synonyms from Alternative Forms(2):
Canonical SMILES: CC(C)N1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)CCCn2c(CCc3cccc(F)c3F)nc(=O)c3ccccc32)CC1.O=C(O)C(O)C(O)C(=O)O
Standard InChI: InChI=1S/C42H43F5N4O2.C4H6O6/c1-28(2)49-25-22-34(23-26-49)51(27-29-12-14-30(15-13-29)31-16-19-33(20-17-31)42(45,46)47)39(52)11-6-24-50-37-10-4-3-8-35(37)41(53)48-38(50)21-18-32-7-5-9-36(43)40(32)44;5-1(3(7)8)2(6)4(9)10/h3-5,7-10,12-17,19-20,28,34H,6,11,18,21-27H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)
Standard InChI Key: BHTXBPYQPIYECL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 730.82 | Molecular Weight (Monoisotopic): 730.3306 | AlogP: 8.83 | #Rotatable Bonds: 12 |
Polar Surface Area: 58.44 | Molecular Species: BASE | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 8.99 | CX LogP: 7.92 | CX LogD: 6.32 |
Aromatic Rings: 5 | Heavy Atoms: 53 | QED Weighted: 0.12 | Np Likeness Score: -1.50 |
1. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF.. (2010) Thousands of chemical starting points for antimalarial lead identification., 465 (7296): [PMID:20485427] [10.1038/nature09107] |
2. St. Jude Leishmania screening dataset., [10.6019/CHEMBL3433997] |
Source(2):